Notably, among these DEGs, MMP-2 was further identified as being significantly correlated with poor OS and prognosis in COAD patients, thereby highlighting its potential as an immune-related biomarker and a prognostic indicator. The gene discussed is MMP2; the disease is colon adenocarcinoma.